There is no explanation on : HY REVENUE on Ordinary Activities down 12.9% to $61mil only.The Net Profit was down because of missing Reval Gains during the previous HY.
- Forums
- ASX - By Stock
- CQE
- Ann: Half Year Results Announcement
Ann: Half Year Results Announcement, page-2
Featured News
Add CQE (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.59 |
Change
-0.020(0.77%) |
Mkt cap ! $965.6M |
Open | High | Low | Value | Volume |
$2.56 | $2.60 | $2.56 | $43.27K | 16.76K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 424 | $2.59 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.60 | 9888 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 424 | 2.590 |
12 | 9814 | 2.580 |
7 | 6620 | 2.570 |
9 | 18476 | 2.560 |
9 | 33905 | 2.550 |
Price($) | Vol. | No. |
---|---|---|
2.600 | 9888 | 20 |
2.610 | 2852 | 7 |
2.620 | 7707 | 8 |
2.630 | 8837 | 7 |
2.640 | 2100 | 1 |
Last trade - 10.57am 13/11/2024 (20 minute delay) ? |
Featured News
CQE (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online